Kris DeVault’s toddler has a rare genetic disease. He’s desperate to try an experimental drug, even though it has not been ...

Companies like Synchron, Paradromics, and Precision Neuroscience are also racing to develop brain implants This article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter ...

In June 2024, a small company called Zanskar purchased a geothermal power plant in New Mexico that was failing fast. The ...

Once its treatment is rubber-stamped, the company can sell it via experimental treatment clinics, the first of which is ...

It makes it easy to trick them into doing things they shouldn’t, such as telling you how to sabotage an aircraft’s navigation ...

We got a sneak peek inside Found Energy’s lab, just as it gears up to supply heat and hydrogen to its first customer. The crushed-up soda can disappears in a cloud of steam and—though it’s not visible ...

The company says it is on track to build a new kind of machine based on topological qubits. Microsoft announced today that it has made significant progress in its 20-year quest to make topological ...

The state’s effort to expand the “right to try” is making headway, and the first drugs are about to be reviewed.

One year on from the White House's voluntary commitments on AI. This story originally appeared in The Algorithm, our weekly newsletter on AI. To get stories like this in your inbox first, sign up here ...

It feels bad enough when an open letter signed by leading economists warns that AI might steal your job. The fact it may soon ...

As generative AI captures public attention, a different kind of AI is reshaping drug discovery. Machine learning models are ...

As the AI boom heats up, the semiconductor titans are waging a fierce talent war with flashy bonuses, aggressive recruiting, ...